Chongqing Precision Biotech Co., Ltd.
PrivateLast Round
Series C
Feb 4, 2024
Company Overview
Chongqing Precision Biotech Co., Ltd. operates in Healthcare & Life Sciences and is based in Chongqing. Its latest recorded funding round was a Series B Extension round in October 2023.
Chongqing Precision Biotech Co., Ltd. is a biotechnology company that develops gene and cell therapy products, including CAR-T and CAR-NK cell therapies for the treatment of malignant tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chongqing Precision Biotech Co., Ltd. Comparables
Compare Chongqing Precision Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Juventas Cell Therapy Ltd. | 89% | |
| PersonGen BioTherapeutics | 88% | |
| Shanghai Unicar-Therapy Bio-medicine Technology | 87% |
For institutional investors. Book with your work email.
Chongqing Precision Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 4, 2024 | ||||
| Series B Extension | Oct 18, 2023 | ||||
| Series B | Apr 12, 2023 | ||||
| Series A Extension | Aug 3, 2020 | ||||
| Series A | Jan 1, 2020 | ||||
Angel | Aug 4, 2016 |
For institutional investors. Book with your work email.
Chongqing Precision Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2020
Completed a Series A Extension round of funding.
- Jan 1, 2020
Completed a Series A funding round.
For institutional investors. Book with your work email.
Chongqing Precision Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Chongqing Precision Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Chongqing Precision Biotech Co., Ltd. a public or private company?
Chongqing Precision Biotech Co., Ltd. is a private company.
What is the current stock price of Chongqing Precision Biotech Co., Ltd.?
Chongqing Precision Biotech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Chongqing Precision Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Chongqing Precision Biotech Co., Ltd. worth (valuation)?
Valuation information for Chongqing Precision Biotech Co., Ltd. is not publicly available.
Can I buy Chongqing Precision Biotech Co., Ltd. stock?
Chongqing Precision Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Chongqing Precision Biotech Co., Ltd.'s last funding round?
Chongqing Precision Biotech Co., Ltd.'s most recent funding round was Series C on February 4, 2024.
Who are the main investors in Chongqing Precision Biotech Co., Ltd.?
Key investors in Chongqing Precision Biotech Co., Ltd. include Oriental Fortune Capital.
Will Chongqing Precision Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Chongqing Precision Biotech Co., Ltd..
How can I track Chongqing Precision Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Chongqing Precision Biotech Co., Ltd.'s shares on secondary markets.